TABLE 5.
Reactivity of 495 clinical specimens from sexually transmitted disease clinics that were tested qualitatively with CDC synthetic VDRL antigen and BDMS VDRL antigena
| Test and result | No. of Tests | No. of samples with result for antigen:
|
|||
|---|---|---|---|---|---|
| CDC synthetic VDRL antigen
|
BDMS VDRL antigen
|
||||
| Reactive | Nonreactive | Reactive | Nonreactive | ||
| Treponemal; reactive | 38 | 38 | 0 | 36 | 2 |
| Nontreponemal; nonreactive | 457 | 5 | 452 | 7b | 450 |
a
A treponemal test was run as the confirmatory test on reactive specimens.
b
Five of these seven sera were also reactive with the CDC synthetic VDRL antigen.